Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Hemispherx Biopharma, Inc.

Hemispherx Biopharma (NYSE MKT: HEB) is a biopharmaceutical company based in Philadelphia, Pennsylvania. Founded in 1990, the company has 32 employees.

Investment goal date:
Dividends reinvested
Hemispherx Biopharma, Inc. HEB report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-14
--
--
Q3 2017
2017-11-13
--
--
Q2 2017
2017-08-14
0.0000
-0.0800
Q1 2017
2017-05-15
0.0000
-0.1100
Q4 2016
2017-03-31
0.0000
-0.0700
Q3 2016
2016-11-14
0.0000
-0.1300
Q2 2016
2016-08-15
0.0000
-0.1200
Q1 2016
2016-05-16
0.0000
-0.1200
Q4 2015
2016-03-29
0.0000
-0.1200
Q3 2015
2015-11-16
0.0000
-0.2400
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
CARTER WILLIAM A
0.6500% (1225585)
HEB /
PIANI RICHARD
0.0300% (56818)
HEB /
MITCHELL WILLIAM M
0.1100% (199661)
HEB /
ETHERIDGE RANSOM
0.0200% (35714)
HEB /
STRAYER DAVID R
0.0200% (41804)
HEB /
KIANI IRAJ EGHBAL
0.3300% (630886)
HEB /
Equels Thomas K.
0.2600% (492919)
HEB /
Bernhardt Charles Thomas III
0.0900% (177420)
HEB /
Springate Wayne S.
0.0200% (32514)
HEB /
Lander Russel J
0.1100% (207983)
HEB /
Rodino Peter W. III
0.0100% (15873)
HEB /
Pascale Adam
0.0100% (27389)
HEB /
% ()